The role of adipose tissue in the obesity-associated metabolic risks of glucocorticoids

Start Date
Dec. 1, 2017
End Date
Nov. 30, 2018


Glucocorticoids result in adverse metabolic effects including diabetes, NAFLD and weight gain. We have generated preliminary data suggesting that while these risks are present in lean individuals, the consequences are dramatically worse in obese individuals. This proposal aims to identify the molecular and physiological mechanisms that cause these effects by testing effects of obesity on chromatin availability and the role of adipocytes in these effects. Our goal is to identify why and in what tissues obesity causes increased metabolic risk to glucocorticoids.

Which publications were supported by this award?


comments powered by Disqus